Meta Analysis on Primary Non- small Cell Lung Carcinoma （NSCL） Treated by TCM in China

doi:10.13288/j.11-2166/r.1999.05.019

您当前的位置：

首页 >

文章列表页 >

Meta Analysis on Primary Non- small Cell Lung Carcinoma （NSCL） Treated by TCM in China

更新时间：2021-11-20

- Meta Analysis on Primary Non- small Cell Lung Carcinoma （NSCL） Treated by TCM in China
- Journal of Traditional Chinese Medicine Issue 5, Pages: 287-289(1999)
- 作者机构：
  
  1. 河北省肿瘤研究所
  2. 河北省医学科学院附属医院
  3. 河北省医学科学院附属医院石家庄市健康路5号,050011
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.1999.05.019
  CLC： R273
- Published：1999
- 稿件说明：
移动端阅览
[1]陈志峰,李成柱,刘少翔,侯浚,王济民.中医药治疗原发性非小细胞肺癌疗效的Meta分析[J].中医杂志,1999(05):287-289+5.

Meta Analysis on Primary Non- small Cell Lung Carcinoma （NSCL） Treated by TCM in China[J]. Journal of Traditional Chinese Medicine1999, (5): 287-289.
[1]陈志峰,李成柱,刘少翔,侯浚,王济民.中医药治疗原发性非小细胞肺癌疗效的Meta分析[J].中医杂志,1999(05):287-289+5. DOI： 10.13288/j.11-2166/r.1999.05.019.

Meta Analysis on Primary Non- small Cell Lung Carcinoma （NSCL） Treated by TCM in China[J]. Journal of Traditional Chinese Medicine1999, (5): 287-289. DOI： 10.13288/j.11-2166/r.1999.05.019.

摘要

应用Meta分析方法（MA）的随机效应模型

对国内7年来单纯采用中医药治疗原发性非小细胞肺癌（NSCL）

并以化疗作对照的研究文献进行定量合并分析。MA结果显示

中医药组稳定率OR=2.10

95％CI（0.70～3.08）

资料齐性检验Q=24.24

V=12

P>0.01;化疗组有效率OR=1.48

95％CI（1.03～2.24）

Q=2.89

V=8

P>0.05。统计7篇文献中位生存期

中医药组平均335.4天

化疗组231.8天

显著性检验P=0.1489。MA结果表明

中医药治疗NSCL疗效特点为稳定率高

有效率低

但中医药组远期生存显示了一定的优势。

Abstract

Chen Zhifeng

Li Chengzhu

Liu Shaoxiang et al. By applying random - effect model of meta analysis （MA）

quantitative analysis was also made on literatures of non - small cell lung - cancer treated with TCM alone in the past 7 years

with that treated by chemotherapy as control. MA results showed that the stability rate of TCM group was OR = 2. 10

95% CI （0. 70-3. 08）

complete data exam Q = 24. 24

V = 12 F>0. 01. In the themotherapeutic group. OR = 1.48

95% CI （1.03-2. 24）

Q = 2. 89

V = 8

P> 0.05. Statistics from 7 papers revealed the mean survival rate of TCM group was 335. 4 days

that of chemotherapeutic group 231. 8

test of significance P = 0. 1489. MA results showed that the features of TCM treatment on NSCL were: high stability

low effectiveness

however

with certain dominance. Authors’ address: Institute of Oncology

Shijiazhuang

Hebei 050011

关键词

Keywords

references

查看原文

Views

1141

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Report on Primary Lung Carcinoma Treated with Kanglaite Injection

Clinical Observation on the Synergic and Detoxified Action of Injection of Radix Codonopsis and Radix Ophiopogonis in Chemotherapy of Lung Cancer,

Clinical Observation of Hydrothorax in Lung Cancer Patients Treated by Closed Drainage Concerted with Injection of Herba Pruneilae: Report of 26 Cases

Clinical Observation on Non - small Cell Lung Carcinoma Treated by Jinfukang Oral Solution

Syndrome Differentiation and Treatment of Cholinergic Urticaria from the Perspective of "Treating Fire Constraint by Dispersing It"

Related Author

李大鹏

谢长生

杨维泓

沈敏鹤

郭勇

周维顺

王泽时

吴良村

Related Institution

浙江康莱特药业有限公司浙江省杭州市龙井路饮马桥14号

浙江中医学院附属医院肿瘤科

浙江中医学院附属医院肿瘤科杭州市邮电路

上海中医药大学附属曙光医院肿瘤科

上海中医药大学附属曙光医院肿瘤科上海普安路185号

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰